Schedule 13D ownership disclosure

Nexvet Biopharma plc

Security class unavailable · CUSIP: G6503X109

Event date: 2015-02-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422107-15-000024
Form type
SC 13D
Filer
FARALLON CAPITAL MANAGEMENT, L.L.C.
CIK
CIK 909661
Filed
Feb 20, 2015
Reporting period
Feb 10, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub